TORONTO — Apotex Health Corp. says it had a net loss of $38.3 million in its first quarter as its revenue fell from the same period last year.
The pharmaceutical company says the result compared with a profit of $362.7 million in last year’s first quarter.
That amounted to a diluted loss per share of 19 cents during the quarter ended June 30, compared with diluted earnings per share of $1.88 a year ago.
Apotex says its revenue reached $848 million during the quarter, down year-over-year from $1.14 billion.
After 52 years as a private company, Apotex announced on June 16 that it closed its upsized IPO at a price of $24 per share for gross proceeds of nearly $1.5 billion.
Its chief executive Jeff Watson said the money raised from the IPO can be used to reduce debt and provide more flexibility on Apotex’s balance sheet.
This report by The Canadian Press was first published Aug. 12, 2026.
